Marc Martinell

1.1k total citations
32 papers, 510 citations indexed

About

Marc Martinell is a scholar working on Molecular Biology, Physiology and Plant Science. According to data from OpenAlex, Marc Martinell has authored 32 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Physiology and 7 papers in Plant Science. Recurrent topics in Marc Martinell's work include Peroxisome Proliferator-Activated Receptors (6 papers), Chemical Synthesis and Analysis (5 papers) and Metabolism and Genetic Disorders (4 papers). Marc Martinell is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Chemical Synthesis and Analysis (5 papers) and Metabolism and Genetic Disorders (4 papers). Marc Martinell collaborates with scholars based in Spain, United States and Austria. Marc Martinell's co-authors include Ernest Giralt, Cèsar Blanché, Jordi López‐Pujol, Laura Rodríguez‐Pascau, Ricardo Pérez‐Tomás, Beatriz Montaner, Llorenç Sáez, Joan Aymamı́, Rupert Öllinger and Pilar Pizcueta and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Marc Martinell

31 papers receiving 493 citations

Peers

Countries citing papers authored by Marc Martinell

Since Specialization

Citations

This map shows the geographic impact of Marc Martinell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Martinell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Martinell more than expected).

Fields of papers citing papers by Marc Martinell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Martinell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Martinell. The network helps show where Marc Martinell may publish in the future.

Co-authorship network of co-authors of Marc Martinell

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Martinell. A scholar is included among the top collaborators of Marc Martinell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Martinell. Marc Martinell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of the Novel Site-Directed Enzyme Enhancement Therapy (SEE-Tx) Drug Discovery Platform to Identify Pharmacological Chaperones for Glutaric Acidemia Type 1 2024 ·Journal of Medicinal Chemistry ·Madalena Barroso, (unknown), (unknown), Ingrid Goebel, Karl Kuchler, Ania C. Muntau, (unknown), (unknown), Marc Martinell, Xavier Barril, Elena Cubero, Søren W. Gersting	1
2	Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in children 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Laura Rodríguez‐Pascau, (unknown), (unknown), Sílvia Pascual, Sonia Poli, (unknown), (unknown), Alice Ke, Andreas Lindauer, Marc Martinell, Pilar Pizcueta	2
3	Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate 2023 ·International Journal of Molecular Sciences ·Pilar Pizcueta, Cristina Vergara, Marco Emanuele, Anna Vilalta, Laura Rodríguez‐Pascau, Marc Martinell	17
4	Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome 2023 ·Journal of Translational Medicine ·(unknown), C. J. Alejos Grau, Cristina Vergara, Laura Rodríguez‐Pascau, (unknown), (unknown), Soledad Alcántara, Pilar Rodríguez‐Pombo, Pilar Pizcueta, Marc Martinell, Àngels García‐Cazorla, Alfonso Oyarzábal	10
5	PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes 2023 ·Pharmaceutics ·Paolo Santambrogio, Anna Cozzi, Ivano Di Meo, (unknown), Cristina Vergara, Laura Rodríguez‐Pascau, Marc Martinell, Pilar Pizcueta, Valeria Tiranti, Sonia Levi	6
6	Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia 2022 ·Neurology Genetics ·Massimo Pandolfo, Kathrin Reetz, Alejandra Darling, Francisco Javier Rodríguez de Rivera Garrido, Pierre‐Gilles Henry, James M. Joers, Christophe Lenglet, Isaac Adanyeguh, Dinesh K. Deelchand, Fanny Mochel, Françoise Pousset, Sílvia Pascual, (unknown), (unknown), (unknown), (unknown), (unknown), Marc Martinell, (unknown), Alexandra Dürr	17
7	The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy 2021 ·Science Translational Medicine ·Laura Rodríguez‐Pascau, Anna Vilalta, (unknown), (unknown), Sonja Forss‐Petter, Isabelle Weinhofer, Jan Bauer, Stephan Kemp, (unknown), Sílvia Pascual, (unknown), Patricia L. Musolino, Johannes Berger, Marc Martinell, Pilar Pizcueta	27
8	PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia 2020 ·Neurobiology of Disease ·Laura Rodríguez‐Pascau, Elena Britti, Pablo Calap-Quintana, Yi Dong, Cristina Vergara, Fabien Delaspre, (unknown), Jordi Tamarit, Federico V. Pallardó, Pilar González‐Cabo, Joaquim Ros, David R. Lynch, Marc Martinell, Pilar Pizcueta	42
9	Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations 2020 ·PLoS ONE ·Tamara Maes, Cristina Mascaró, David Rotllant, Michele MP Lufino, Angels Estiarte, Nathalie Guibourt, Fernando Cavalcanti, Christian Griñán‐Ferré, Mercè Pallàs, Roser Nadal, Antonio Armario, Isidró Ferrer, Alberto Ortega, Núria Valls, Matthew C. T. Fyfe, Marc Martinell, (unknown), (unknown)	44
10	MIN102 (Leriglitazone), a Brain Penetrant PPAR Gamma Agonist for the Treatment of Friedreich’s Ataxia (4147) 2020 ·Neurology ·Sonia Poli, Laura Rodríguez‐Pascau, Elena Britti, Joaquim Ros, (unknown), David R. Lynch, Marc Martinell, Pilar Pizcueta	3
11	Conservation Genetics ofDichoropetalum schottii(Apiaceae): Is the Legal Protection of Edge Populations Consistent with the Genetic Data? 2013 ·Annales Botanici Fennici ·Jordi López‐Pujol, Marc Martinell, (unknown), Ana Rovira, María Bosch, Julià Molero, Joan Simon, Cèsar Blanché	2
12	Deu anys de seguiment demogràfic i genètic d’Stachys maritima a Catalunya (2001-2010). Implicacions per a un pla de recuperació 2010 ·Collectanea Botanica ·Cèsar Blanché, Carles Barriocanal Lozano, Marc Martinell, (unknown), Jordi López‐Pujol	1
13	Seseli farrenyi: un endemisme empordanès en vies d'extinció? 2010 ·Collectanea Botanica ·Jordi López‐Pujol, Marc Martinell, (unknown), Cèsar Blanché, (unknown)	2
14	Low genetic variability in the rare, recently differentiated Aquilegia paui (Ranunculaceae) 2010 ·Biochemical Systematics and Ecology ·Marc Martinell, Jordi López‐Pujol, María Bosch, Cèsar Blanché	5
15	Synthetic Ligands Able to Interact with the P53 Tetramerization Domain. Towards Understanding a Protein Surface Recognition Event 2006 ·ChemBioChem ·Marc Martinell, Xavier Salvatella, Jimena Fernández‐Carneado, Susana Gordo, Miguel Feliz, Margarita Menéndez, Ernest Giralt	14
16	Cell cycle arrest and proapoptotic effects of the anticancer cyclodepsipeptide serratamolide (AT514) are independent of p53 status in breast cancer cells 2005 ·Biochemical Pharmacology ·Vanessa Soto‐Cerrato, Beatriz Montaner, Marc Martinell, Marta Vilaseca, Ernest Giralt, Ricardo Pérez‐Tomás	21
17	DNA Interaction and Dual Topoisomerase I and II Inhibition Properties of the Anti-Tumor Drug Prodigiosin 2005 ·Toxicological Sciences ·Beatriz Montaner, (unknown), Marc Martinell, Rupert Öllinger, Joan Aymamı́, Ernest Giralt, Ricardo Pérez‐Tomás	81
18	ENPDA: an evolutionary structure-based de novo peptide design algorithm 2005 ·Journal of Computer-Aided Molecular Design ·(unknown), Sergio Madurga, Xavier Llorà, Marc Martinell, Teresa Tarragó, (unknown), Ernesto Nicolás, Ernest Giralt	27
19	Ionic self-complementarity induces amyloid-like fibril formation in an isolated domain of a plant copper metallochaperone protein 2004 ·BMC Structural Biology ·Helena Mira, Marçal Vilar, Vicent Esteve, Marc Martinell, Marcelo J. Kogan, Ernest Giralt, David Salom, Ismael Mingarro, Lola Peñarrubia, Enríque Pérez‐Payá	16
20	A Tetraguanidinium Ligand Binds to the Surface of the Tetramerization Domain of Protein P53 2003 ·Angewandte Chemie International Edition ·Xavier Salvatella, Marc Martinell, Margarida Gairí, Mauricio G. Mateu, Miguel Feliz, Andrew D. Hamilton, Javier de Mendoza, Ernest Giralt	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact